Disease-modifying treatments for multiple sclerosis – a review of approved medications

BACKGROUND AND PURPOSE: There is still no curative treatment for multiple sclerosis (MS), but during the last 20 years eight different disease-modifying compounds have been approved for relapsing−remitting MS (RRMS). METHODS: A literature search was conducted on published randomized controlled phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Torkildsen, Ø, Myhr, K-M, Bø, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2016
Materias:
Annual Meeting of the Norwegian Neurological Association – March 2014. Guest Editors: Kjell-Morten Myhr, Lars Jacob Stovner, Sigrid Svalheim, Nils Erik Gilhus. Publication of This Supplement was Supported by the Norwegian Neurological Association
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670697/
https://www.ncbi.nlm.nih.gov/pubmed/26563094
http://dx.doi.org/10.1111/ene.12883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670697/
https://www.ncbi.nlm.nih.gov/pubmed/26563094
http://dx.doi.org/10.1111/ene.12883

Ejemplares similares